Literature DB >> 30277463

Paclitaxel density and clinical efficacy of drug-coated balloon angioplasty for femoropopliteal artery disease: meta-analysis and adjusted indirect comparison of 20 randomised trials.

Salvatore Cassese1, Gjin Ndrepepa, Michele Fusaro, Sebastian Kufner, Erion Xhepa, Massimiliano Fusaro.   

Abstract

Entities:  

Year:  2019        PMID： 30277463     DOI： 10.4244/EIJ-D-18-00550

Source DB:  PubMed          Journal:  EuroIntervention        ISSN： 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  2 in total

1.  Improvement of Outcome for Treatment of 'Restenosis-prone' Vascular Lesions? Potential Impact of the Paclitaxel dose on Late Lumen Loss in Porcine Peripheral Arteries.

Authors:  Ole Gemeinhardt; Tobias Haase; Beatrix Schnorr; Jing Xie; Melanie Löchel; Denise Schütt; Antje Mittag; Wolfram Haider; Stephanie Bettink; Ulrich Speck; Gunnar Tepe
Journal:  Cardiovasc Intervent Radiol       Date:  2022-09-15       Impact factor: 2.797

2.  Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials.

Authors:  Christof Klumb; Thomas Lehmann; René Aschenbach; Niklas Eckardt; Ulf Teichgräber
Journal:  EClinicalMedicine       Date:  2019-10-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.